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journal homepage: www.jfma-onl ine.comLETTER TO THE EDITORComments on “Progression of stages 3be5
chronic kidney diseasedPreliminary results of
Taiwan national pre-ESRD disease management
program in Southern Taiwan”To the Editor,
I read with interest the article by Lin et al,1 who investi-
gated the progression of renal function and mortality
among stage 3be5 chronic kidney disease (CKD) patients
from the pre-end-stage renal disease (ESRD) disease man-
agement program. This study provided important messages
about the annual glomerular filtration rate change with or
without diabetes in different CKD stages in Taiwan. In
addition, the authors identified the risk factors for initi-
ating dialysis using the Cox proportional hazard model.
However, there are several concerns on this report.
First, patients in pre-ESRD status had a high risk of
developing cardiovascular disease, which may lead to death
prior to ESRD.2 To consider the potential for the competing
risk of death and ESRD among patients of CKD stage 3be5, I
propose that a competing risk model, either cause-specific
proportional hazard model or Fine and Gray model, may be
a better option of analyzing the risk factors of competing
outcomes in this population group.3 According to risk fac-
tors identified for ESRD and pre-ESRD death separately, an
individualized prevention strategy can be made properly.
Second, in this analysis, age is a protective factor for
dialysis treatment with a hazard ratio of 0.99 (95% confi-
dence interval, 0.98e0.99; p Z 0.026). A previous study
found that competing risk between renal failure and death
may be more pronounced among older patients.4 It will be
interesting to know the outcomes across different age
groups among stage 3be5 CKD patients in Taiwanese data.Conflicts of interest: The author has no conflicts of interest
relevant to this article.
http://dx.doi.org/10.1016/j.jfma.2014.08.005
0929-6646/Copyright ª 2014, Elsevier Taiwan LLC & Formosan MedicaReferences
1. Lin CM, Yang MC, Hwang SJ, Sung JM. Progression of stages 3be5
chronic kidney diseasePreliminary results of Taiwan National
Pre-ESRD disease management in Southern Taiwan. J Formos
Med Assoc 2013;112:773e82.
2. Herzog CA, Asinger RW, Berger AK, Charytan DM, Dı´ez J,
Hart RG, et al. Cardiovascular disease in chronic kidney disease.
A clinical update from Kidney Disease: Improving Global Out-
comes (KDIGO). Kidney Int 2011;80:572e86.
3. Fine JP, Gray RJ. A proportional hazards model for the sub-
distribution of a competing risk. J Am Stat Assoc 1999;94:
496e509.
4. De Nicola L, Minutolo R, Chiodini P, Borrelli S, Zoccali C,
Postorino M, et al. The effect of increasing age on the prognosis
of non-dialysis patients with chronic kidney disease receiving
stable nephrology care. Kidney Int 2012;82:482e8.
Tai Shuan Lai*
Department of Internal Medicine, National Taiwan
University Hospital Bei-Hu Branch, Taipei, Taiwan
*Department of Internal Medicine, National Taiwan
University Hospital Bei-Hu Branch, Number 87,
Neijiang Street, Taipei 108, Taiwan.
E-mail address: d99849016@ntu.edu.tw
17 June 2014l Association. All rights reserved.
